Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 50Unknown 15Recruiting 13Terminated 10Active not recruiting 8Withdrawn 5Not yet recruiting 2Suspended 1No longer available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 6Colorectal Neoplasms 2Unresectable Locally Advanced or Metastatic Solid Tumors 1HER2-positive Colorectal Cancer 1HER2 IHC3+ Advanced Colorectal Cancer 1Gastrointestinal Stromal Tumors 1Disease Progression 1Cirrhosis, Familial, with Pulmonary Hypertension 1Cholangiocarcinoma 1

Interventions

Bevacizumab 37Oxaliplatin 17Capecitabine 17Irinotecan 15Leucovorin 13HMPL-013 12Fluorouracil 12Cetuximab 11trifluridine tipiracil drug combination 7irinotecan sucrosofate 6tipiracil 5Trifluridine 5Specimen Handling 5Drug Therapy 5tislelizumab 4Standard of Care 4Mitomycin 4Magnetic Resonance Spectroscopy 4Injections 4Folfox protocol 4trametinib 3toripalimab 3pembrolizumab 3Nivolumab 3IFL protocol 3Colonoscopy 3Blood Specimen Collection 3Biopsy 3sotorasib 2sintilimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Colorectal Neoplasms × regorafenib × Clear all
NCT06283134 2026-01-07

A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

China Medical University, China

Phase 1 Not yet recruiting
60 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07134205 2025-08-21

The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer

Shanghai JMT-Bio Inc.

Phase 3 Not yet recruiting
252 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡